Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

CRDL.US - Current Price

$0.96

Company Information

▼
Company Name
Cardiol Therapeutics Inc Class A
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: CA14161Y2006
CIK: 0001702123
Currency: USD
Full Time Employees: 18
Phone: 289 910 0850
Website: https://www.cardiolrx.com
Fiscal Year End: December
IPO Date: Jan 15, 2019
Description:

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Address:

2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5

Directors & Officers

▼
Name Title Year Born
Mr. David G. Elsley MBA President, CEO & Director NA
Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA CFO, Corporate Secretary & Director NA
Mr. Bernard Lim B.Sc. Chief Operating Officer NA
Dr. Andrew Warwick Hamer M.D. Chief Medical Officer and Head of Research & Development 1962
Trevor Burns Investor Relations NA
Mr. John A. Geddes BSCPT, MBA Vice President of Corporate Development NA

Shares Statistics

▼
Shares Outstanding: 100.00M
Shares Float: 84.42M
% Insiders: 352.30%
% Institutions: 1,123.60%
Short % Float: 2.19%

Valuation Metrics

▼
Enterprise Value: $88.76M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $96.00M
EBITDA: $-36.41M
Book Value: $0.08
Earnings/Share: $-0.29
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -148.83%
ROE (TTM): -347.98%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Mar 31, 2026 0.00 -0.07 N/A 10,000.00%
Sep 30, 2025 -0.09 -0.08 N/A -1,058.06%
Jun 30, 2025 -0.07 -0.10 N/A 2,758.27%
Mar 31, 2025 -0.10 -0.08 N/A -2,500.00%
Dec 31, 2024 -0.09 -0.12 N/A 2,287.92%
Sep 30, 2024 -0.18 -0.08 N/A -12,500.00%
Jun 30, 2024 -0.10 -0.13 N/A 2,307.69%
Mar 31, 2024 -0.12 -0.12 N/A 0.00%
Dec 31, 2023 -0.09 -0.09 N/A 0.00%
Sep 30, 2023 -0.09 -0.12 N/A 2,500.00%
Jun 30, 2023 -0.12 -0.12 N/A 0.00%
Mar 31, 2023 -0.11 -0.15 N/A 2,666.67%
Dec 31, 2022 -0.12 -0.15 N/A 2,000.00%
Sep 30, 2022 -0.13 -0.14 N/A 714.29%
Jun 30, 2022 -0.10 -0.15 N/A 3,333.33%
Mar 31, 2022 -0.14 -0.15 N/A 666.67%
Dec 31, 2021 -0.11 -0.14 N/A 2,142.86%
Sep 30, 2021 -0.18 -0.18 N/A -22.31%
Jun 30, 2021 -0.16 -0.14 N/A -1,428.57%
Mar 31, 2021 -0.26 -0.14 N/A -8,571.43%
Dec 31, 2020 -0.15 -0.12 N/A -2,500.00%
Sep 30, 2020 -0.10 -0.07 N/A -4,919.00%
Jun 30, 2020 -0.10 0.00 N/A N/A
Mar 31, 2020 -0.11 -0.16 N/A 3,125.00%
Dec 31, 2019 -0.12 -0.13 N/A 769.23%
Sep 30, 2019 -0.09 0.00 N/A N/A
Jun 30, 2019 -0.10 0.00 N/A N/A
Mar 31, 2019 -0.10 -0.07 N/A -4,393.49%
Dec 31, 2018 -0.10 0.00 N/A N/A
Sep 30, 2018 -0.41 0.00 N/A N/A
Jun 30, 2018 -0.25 0.00 N/A N/A
Mar 31, 2018 -0.07 0.00 N/A N/A
Dec 31, 2017 -0.03 0.00 N/A N/A
Sep 30, 2017 -0.03 0.00 N/A N/A
Jun 30, 2017 -0.03 0.00 N/A N/A
Mar 31, 2017 -0.03 0.00 N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $30.58M $N/A $31.86M $7.14M $24.73M
2023-12-31 $34.93M $N/A $36.70M $8.45M $28.25M
2022-12-31 $43.83M $N/A $45.76M $7.25M $38.51M
2021-12-31 $83.90M $N/A $87.88M $11.64M $76.24M
2020-12-31 $14.03M $N/A $15.89M $2.62M $13.27M
2019-12-31 $6.96M $N/A $15.50M $830.83K $14.67M
2018-12-31 $16.73M $N/A $24.68M $2.41M $22.27M
2017-12-31 $2.36M $N/A $3.22M $366.76K $2.85M

Watchlist

0

No stocks in watchlist